Medical Group

Annals of Antivirals and Antiretrovirals



Advertise with us

Molecular Docking studies on possible Neuraminidase Inhibitors of Influenza Virus

Published On: October 10, 2017 | Pages: 005 - 007

Author(s): Jawaria Khan*, Ardas Masood, Asma Noor, Anam Munir and Muhammad Imran Qadir
Influenza generally known as flu is due to viruses that contaminate the respiratory region. It can result in light to cruel sickness, and may cause death. The influenza pandemic of 1918-1919 took life of a lot more people than the World War 1. Peramivir that inhibits the purpose of the viral neuraminidase protein of influenza virus, therefore stopping the virus from r ...
View Article View Abstract

Lack of Difference between the Reduced Dose and Full-Dose of Antiretroviral Therapy in Terms of the Decrease in Immune Activation

Published On: January 28, 2017 | Pages: 001 - 004

Author(s): Nicolè S*, Cucchetto G, Lanzafame M, Rigo F, Lattuada E, Concia E and Vento S
Virological and immunological effectiveness of reduced doses of antiretrovirals has been shown in two randomized trials and smaller studies. We have now evaluated immune activation in patients on reduced doses of antiretroviral therapy (ART) using HLA-DR+CD8+ lymphocytes as a marker of activation. ...
View Article View Abstract